Related references
Note: Only part of the references are listed.Evaluating Candidate Principal Surrogate Endpoints
Peter B. Gilbert et al.
BIOMETRICS (2008)
A framework for assessing immunological correlates of protection in vaccine trials
Li Qin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Augmented designs to assess immune response in vaccine trials
Dean Follmann
BIOMETRICS (2006)
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges
Shambavi Subbarao et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges
Dennis Ellenberger et al.
VIROLOGY (2006)
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges
RR Regoes et al.
PLOS MEDICINE (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Bias reduction for risk ratio and vaccine effect estimators
SE Chick et al.
STATISTICS IN MEDICINE (2001)
Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines
PA Czeschinski et al.
VACCINE (2000)
Share Paper
